Adenomyosis and fertility: a modern view of the problem. A literature review

Abstract

This literature review is based on resources from the following databases: CyberLeninka, PubMed, MedArt, and the Central Scientific Medical Library (I.M. Sechenov First Moscow State Medical University, Moscow, Russia). Adenomyosis is a common non-infectious uterine pathology associated with the risk of infertility and obstetric problems. The local inflammation that develops in adenomyosis reduces the probability of blastocyst implantation and creates an unfavorable environment for the development of the embryo. Adenomyosis reduces the effectiveness of assisted reproductive technology. During the pregnancy in adenomyosis, the risk of incomplete and prolonged pregnancy increases at almost all stages. Besides, the risk of massive hemorrhage increases during pregnancy, childbirth and the early postpartum period. The presented review helps to assess the pathogenetic mechanisms underlying the negative effect of adenomyosis on women’s fertility based on data obtained over the past ten years.

Keywords

adenomyosis / fertility / in vitro fertilization / gestation

References

[1] Kogan EA, Paramonova NB, Shklyar AA, et al. Clinical and morphological features of focal, nodular and diffuse forms of adenomyosis. Archive of Obstetrics and Gynecology named after VF Snegirev. 2016;3(1):18−22. (In Russ.). DOI: 10.18821/2313-8726-2016-3-1-18-22

[2] Коган Е.А., Парамонова Н.Б., Шкляр А.А. и др. Клинико-морфологические особенности очаговой, узловой и диффузной форм аденомиоза // Архив акушерства и гинекологии им. В.Ф. Снегирева. 2016. Т. 3. № 1. С. 18−22. DOI: 10.18821/2313-8726-2016-3-1-18-22

[3] Linde VA, Tatarova NA. Endometrioses. Moscow: GEOTAR-Medicine; 2010.

[4] Линде В.А., Татарова Н.А. Эндометриозы. Москва: ГЭОТАР-Медиа, 2010.

[5] Jendometrioz. Klinicheskie rekomendacii. Moscow, 2020. [cited 5 Dec 2021]. Available from: https://www.dzhmao.ru/spez/klin_recom/akushGinekol/2020/KR_259_endometrioz.pdf

[6] Эндометриоз. Клинические рекомендации. Москва, 2020. [дата обращения 05.12.2021]. Доступ по ccылке: https://www.dzhmao.ru/spez/klin_recom/akushGinekol/2020/KR_259_endometrioz.pdf

[7] Gorpenko AA, Chuprynin VD, Buralkin NA, Safronova AS. Improvement in methods of surgical treatment of adenomyosis diffuse nodular form. Medical council. 2019;21:240−245. DOI: 10.21518/2079-701X2019-21-254-259

[8] Горпенко А.А., Чупрынин В.Д., Буралкин Н.А., Сафронова А.С. Усовершенствование методов хирургического лечения диффузно-узловой формы аденомиоза // Медицинский совет. 2019. № 21. С. 240−245. DOI: 10.21518/2079-701X-2019-21-254-259

[9] Abaykhanova LM. Uterine adenomyosis − symptoms and treatment. In: Science. Education. Innovations: Collection of scientific papers based on the materials of the XII International Scientific and Practical Conference. Anapa; 2019:51−54. [cited 6 Dec 2021]. Available from: https://innova-science.ru/wp-content/uploads/2019/11/sbornik-nauchnyh-trudov-12.11.2019-noi-12.pdf

[10] Абайханова Л.М. Аденомиоз матки — симптомы и лечение // Наука. Образование. Инновации: сборник научных трудов по материалам XII Междунар. науч.-практ. конф., 12 нояб. 2019 г. Анапа, 2019. С. 51−54. [дата обращения 06.12.2021]. Доступ по ссылке: https://innova-science.ru/wp-content/uploads/2019/11/sbornik-nauchnyh-trudov-12.11.2019-noi-12.pdf

[11] Dobrynina ML, Batrak NV, Kryazheva EO, Malyshkina AI. Techniques of adenomyosis diagnosis: peculiarities of application and efficacy. Bulletin of the Ivanovo Medical Academy. 2020;25(1):43−45.

[12] Добрынина М.Л., Батрак Н.В., Кряжева Е.О., Малышкина А.И. Особенности применения и эффективность методов диагностики аденомиоза // Вестник ИвГМА. 2020. Т. 25. № 1. С. 43−45.

[13] Pomortsev AV, Grushevskaya YuV, Makukhina TB. Controversial issues of radiation diagnosis of adenomyosis in patients with reproductive losses. Kuban Scientific Medical Bulletin. 2019;(2):173−190. DOI: 10.25207/1608-6228-2019-26-2-173-190

[14] Поморцев А.В., Грушевская Ю.В., Макухина Т.Б. Спорные вопросы лучевой диагностики аденомиоза при репродуктивных потерях // Кубанский научный медицинский вестник. 2019. № 2. С. 173−190. DOI: 10.25207/1608-6228-2019-26-2-173-190

[15] Adamjan LV, Andreeva EN, Apolihina IA, et al. Sochetannye dobrokachestvennye opuholi i giperplasticheskie processy matki (mioma, adenomioz, giperplazija jendometrija). Moscow; 2015.

[16] Адамян Л.В., Андреева Е.Н., Аполихина И.А. и др. Сочетанные доброкачественные опухоли и гиперпластические процессы матки (миома, аденомиоз, гиперплазия эндометрия). Москва, 2015.

[17] Di Donato N, Montanari G, Benfenati A, et al. Prevalence of adenomyosis in women undergoing surgery for endometriosis. Eur J Obstet Gynecol Reprod Biol. 2014;181:289−293. DOI: 10.1016/j.ejogrb.2014.08.016

[18] Di Donato N., Montanari G., Benfenati A. et al. Prevalence of adenomyosis in women undergoing surgery for endometriosis // Eur. J. Obstet. Gynecol. Reprod. Biol. 2014. Vol. 181. P. 289−293. DOI: 10.1016/j.ejogrb.2014.08.016

[19] Struble J, Reid S, Bedaiwy MA. Adenomyosis: A clinical review of a challenging gynecologic condition. J Minim Invasive Gynecol. 2016;23(2):164−185. DOI: 10.1016/j.jmig.2015.09.018

[20] Struble J., Reid S., Bedaiwy M.A. Adenomyosis: A clinical review of a challenging gynecologic condition // J. Minim. Invasive Gynecol. 2016. Vol. 23. No. 2. P. 164−185. DOI: 10.1016/j.jmig.2015.09.018

[21] Benagiano G, Brosens I, Habiba M. Adenomyosis: a life-cycle approach. Reprod Biomed Online. 2015;30(3):220−232. DOI: 10.1016/j.rbmo.2014.11.005

[22] Benagiano G., Brosens I., Habiba M. Adenomyosis: a life-cycle approach // Reprod. Biomed. Online. 2015. Vol. 30. No. 3. P. 220−232. DOI: 10.1016/j.rbmo.2014.11.005

[23] Pinzauti S, Lazzeri L, Tosti C, et al. Transvaginal sonographic features of diffuse adenomyosis in 18-30-year-old nulligravid women without endometriosis: association with symptoms. Ultrasound Obstet Gynecol. 2015;46(6):730−736. DOI: 10.1002/uog.14834

[24] Pinzauti S., Lazzeri L., Tosti C. et al. Transvaginal sonographic features of diffuse adenomyosis in 18-30-year-old nulligravid women without endometriosis: association with symptoms // Ultrasound Obstet. Gynecol. 2015. Vol. 46. No. 6. P. 730−736. DOI: 10.1002/uog.14834

[25] Benaglia L, Cardellicchio L, Leonardi M, et al. Asymptomatic adenomyosis and embryo implantation in IVF cycles. Reprod Biomed Online. 2014;29(5):606−611. DOI: 10.1016/j.rbmo.2014.07.021

[26] Benaglia L., Cardellicchio L., Leonardi M. et al. Asymptomatic adenomyosis and embryo implantation in IVF cycles // Reprod. Biomed. Online. 2014. Vol. 29. No. 5. P. 606−611. DOI: 10.1016/j.rbmo.2014.07.021

[27] Reznik MV, Tarasenkova VA, Sobakina DA, Linde VA. Adenomyosis and uterine fibroids in Terms of comorbidity (literature review). Journal of scientific articles “Health and education in the XXI century”. 2019;21(2):43−47. DOI: 10.26787/nydha-2226-7425-2019-21-2-43-47

[28] Резник М.В., Тарасенкова В.А., Собакина Д.А., Линде В.А. Аденомиоз и миома матки с точки зрения коморбидности // Журнал научных статей «Здоровье и образование в XXI веке». 2019. Т. 21. № 2. С. 43−47. DOI: 10.26787/nydha-2226-7425-2019-21-2-43-47

[29] Khan KN, Kitajima M, Hiraki K, et al. Involvement of hepatocyte growth factor-induced epithelial-mesenchymal transition in human adenomyosis. Biol Reprod. 2015;92(2):35. DOI: 10.1095/biolreprod.114.124891

[30] Khan K.N., Kitajima M., Hiraki K. et al. Involvement of hepatocyte growth factor-induced epithelial-mesenchymal transition in human adenomyosis // Biol. Reprod. 2015. Vol. 92. No. 2. P. 35. DOI: 10.1095/biolreprod.114.124891

[31] Kok VC, Tsai HJ, Su CF, Lee CK. The risks for ovarian, endometrial, breast, colorectal, and other cancers in women with newly diagnosed endometriosis or adenomyosis: A population-based study. Int J Gynecol Cancer. 2015;25(6):968−976. DOI: 10.1097/IGC.0000000000000454

[32] Kok V.C., Tsai H.J., Su C.F., Lee C.K. The risks for ovarian, endometrial, breast, colorectal, and other cancers in women with newly diagnosed endometriosis or adenomyosis: A population-based study // Int. J. Gynecol. Cancer. 2015. Vol. 25. No. 6. P. 968−976. DOI: 10.1097/IGC.0000000000000454

[33] Liu X, Shen M, Qi Q, et al. Corroborating evidence for platelet-induced epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the development of adenomyosis. Hum Reprod. 2016;31(4):734−749. DOI: 10.1093/humrep/dew018

[34] Liu X., Shen M., Qi Q. et al. Corroborating evidence for platelet-induced epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the development of adenomyosis // Hum. Reprod. 2016. Vol. 31. No. 4. P. 734−749. DOI: 10.1093/humrep/dew018

[35] Streuli I, Santulli P, Chouzenoux S, et al. Activation of the MAPK/ERK cell-signaling pathway in uterine smooth muscle cells of women with adenomyosis. Reprod Sci. 2015;22(12):1549−1560. DOI: 10.1177/1933719115589410

[36] Streuli I., Santulli P., Chouzenoux S. et al. Activation of the MAPK/ERK cell-signaling pathway in uterine smooth muscle cells of women with adenomyosis // Reprod. Sci. 2015. Vol. 22. No. 12. P. 1549−1560. DOI: 10.1177/1933719115589410

[37] Jiang JF, Sun AJ, Xue W, et al. Aberrantly expressed long noncoding RNAs in the eutopic endometria of patients with uterine adenomyosis. Eur J Obstet Gynecol Reprod Biol. 2016;199:32−37. DOI: 10.1016/j.ejogrb.2016.01.033

[38] Jiang J.F., Sun A.J., Xue W. et al. Aberrantly expressed long noncoding RNAs in the eutopic endometria of patients with uterine adenomyosis // Eur. J. Obstet. Gynecol. Reprod. Biol. 2016. Vol. 199. P. 32−37. DOI: 10.1016/j.ejogrb.2016.01.033

[39] Benagiano G, Habiba M, Brosens I. The pathophysiology of uterine adenomyosis: an update. Fertil Steril. 2012;98(3):572−579. DOI: 10.1016/j.fertnstert.2012.06.044

[40] Benagiano G., Habiba M., Brosens I. The pathophysiology of uterine adenomyosis: an update // Fertil. Steril. 2012. Vol. 98. No. 3. P. 572−579. DOI: 10.1016/j.fertnstert.2012.06.044

[41] Vannuccini S, Tosti C, Carmona F, et al. Pathogenesis of adenomyosis: an update on molecular mechanisms. Reprod Biomed Online. 2017;35(5):592−601. DOI: 10.1016/j.rbmo.2017.06.016

[42] Vannuccini S., Tosti C., Carmona F. et al. Pathogenesis of adenomyosis: an update on molecular mechanisms // Reprod. Biomed. Online. 2017. Vol. 35. No. 5. P. 592−601. DOI: 10.1016/j.rbmo.2017.06.016

[43] Spitzer TL, Rojas A, Zelenko Z, et al. Perivascular human endometrial mesenchymal stem cells express pathways relevant to self-renewal, lineage specification, and functional phenotype. Biol Reprod. 2012;86(2):58. DOI: 10.1095/biolreprod.111.095885

[44] Spitzer T.L., Rojas A., Zelenko Z. et al. Perivascular human endometrial mesenchymal stem cells express pathways relevant to self-renewal, lineage specification, and functional phenotype // Biol. Reprod. 2012. Vol. 86. No. 2. P. 58. DOI: 10.1095/biolreprod.111.095885

[45] Davydov DA. Lejomioma i adenomioz: sushhestvuet li edinaja stvolovaja kletka-predshestvennica? Medicinskij zhurnal. 2013;3(45):132−134. (In Russ.)

[46] Давыдов Д.А. Лейомиома и аденомиоз: существует ли единая стволовая клетка-предшественница? // Медицинский журнал. 2013. № 3 (45). С. 132−134.

[47] Wang J, Deng X, Yang Y, et al. Expression of GRIM-19 in adenomyosis and its possible role in pathogenesis. Fertil Steril. 2016;105(4):1093−1101. DOI: 10.1016/j.fertnstert.2015.12.019

[48] Wang J., Deng X., Yang Y. et al. Expression of GRIM-19 in adenomyosis and its possible role in pathogenesis // Fertil. Steril. 2016. Vol. 105. No. 4. P. 1093−1101. DOI: 10.1016/j.fertnstert.2015.12.019

[49] Shang WQ, Yu JJ, Zhu L, et al. Blocking IL-22, a potential treatment strategy for adenomyosis by inhibiting crosstalk between vascular endothelial and endometrial stromal cells. Am J Transl Res. 2015;7(10):1782−1797.

[50] Shang W.Q., Yu J.J., Zhu L. et al. Blocking IL-22, a potential treatment strategy for adenomyosis by inhibiting crosstalk between vascular endothelial and endometrial stromal cells // Am. J. Transl. Res. 2015. Vol. 7. No. 10. P. 1782−1797.

[51] Dueholm M. Uterine adenomyosis and infertility, review of reproductive outcome after in vitro fertilization and surgery. Acta Obstet Gynecol Scand. 2017;96(6):715−726. DOI: 10.1111/aogs.13158

[52] Dueholm M. Uterine adenomyosis and infertility, review of reproductive outcome after in vitro fertilization and surgery // Acta Obstet. Gynecol. Scand. 2017. Vol. 96. No. 6. P. 715−726. DOI: 10.1111/aogs.13158

[53] Llarena N, Flyckt R. Strategies to preserve and optimize fertility for patients with rndometriosis. J Endom Pelvic Pain Dysord. 2017;9(2):98−104. DOI: 10.5301/jeppd.5000278

[54] Llarena N., Flyckt R. Strategies to preserve and optimize fertility for patients with endometriosis // J. Endom. Pelvic Pain Dysord. 2017. Vol. 9. № 2. Р. 98−104. DOI: 10.5301/jeppd.5000278

[55] Jendometrioz: diagnostika, lechenie i reabilitacija. Pis’mo Minzdrava RF. 22.11.2013 No. 15-4/10/2-8710. [cited 06 Dec 2021]. Available from: http://zdrav.spb.ru/media/filebrowser/%D1%8D%D0%BD%D0%B4%D0%BE%D0%BC%D0%B5%D1%82%D1%80%D0%B8%D0%BE%D0%B7_%D0%B4%D0%B8%D0%B0%D0%B3%D0%BD%D0%BE%D1%81%D1%82%D0%B8%D0%BA%D0%B0%2C_%D0%BB%D0%B5%D1%87%D0%B5%D0%BD%D0%B8%D0%B5_%D0%B8_%D1%80%D0%B5%D0%B0%D0%B1%D0%B8%D0%BB%D0%B8%D1%82%D0%B0%D1%86%D0%B8%D1%8F.pdf

[56] Эндометриоз: диагностика, лечение и реабилитация. Письмо Минздрава РФ. 22.11.2013 № 15-4/10/2-8710. [дата обращения 06.12.2021]. Доступ по ссылке: http://zdrav.spb.ru/media/filebrowser/%D1%8D%D0%BD%D0%B4%D0%BE%D0%BC%D0%B5%D1%82%D1%80%D0%B8%D0%BE%D0%B7_%D0%B4%D0%B8%D0%B0%D0%B3%D0%BD%D0%BE%D1%81%D1%82%D0%B8%D0%BA%D0%B0%2C_%D0%BB%D0%B5%D1%87%D0%B5%D0%BD%D0%B8%D0%B5_%D0%B8_%D1%80%D0%B5%D0%B0%D0%B1%D0%B8%D0%BB%D0%B8%D1%82%D0%B0%D1%86%D0%B8%D1%8F.pdf

[57] Bezhenar’ VF, Kuz’mina NS, Kalugina AS. Besplodie pri jendometrioze. Patogeneticheskie aspekty. Pros & cons hirurgicheskogo podhoda k probleme i vspomogatel’nye reproduktivnye tehnologii. Jendometrioz. Patogenez, diagnostika, lechenie. Ed. by S.O. Dubrovina, V.F. Bezhenar’. Moscow: GJeOTAR-Media; 2020. P. 215–237.

[58] Беженарь В.Ф., Кузьмина Н.С., Калугина А.С. Бесплодие при эндометриозе. Патогенетические аспекты. Pros & cons хирургического подхода к проблеме и вспомогательные репродуктивные технологии // Эндометриоз. Патогенез, диагностика, лечение / под ред. С.О. Дубровина, В.Ф. Беженаря. Москва: ГЭОТАР-Медиа, 2020. С. 215–237.

[59] Оrazov МR. Impairment of fertility in women with pain syndrome of adenomyosis. Health of Woman. 2014;(1):139−142.

[60] Оразов М.Р. Нарушение фертильности у женщин с болевым синдромом при аденомиозе // Здоровье женщины. 2014. № 1 (87). С. 139−142.

[61] Vercellini P, Consonni D, Barbara G, et al. Adenomyosis and reproductive performance after surgery for rectovaginal and colorectal endometriosis: a systematic review and meta-analysis. Reprod Biomed Online. 2014;28(6):704−713. DOI: 10.1016/j.rbmo.2014.02.006

[62] Vercellini P., Consonni D., Barbara G. et al. Adenomyosis and reproductive performance after surgery for rectovaginal and colorectal endometriosis: a systematic review and meta-analysis // Reprod. Biomed. Online. 2014. Vol. 28. No. 6. P. 704−713. DOI: 10.1016/j.rbmo.2014.02.006

[63] Zhigalenko AR, Karakhalis LYu, Papova NS. Clinicodiagnostic parallels in adenomyosis-related infertility. Kuban Scientific Medical Bulletin. 2017;24(4):65−73. DOI: 10.25207/1608-6228-2017-24-4-65-73

[64] Жигаленко А.Р., Карахалис Л.Ю., Папова Н.С. Клинико-диагностические параллели при аденомиоз-ассоциированном бесплодии // Кубанский научный медицинский вестник. 2017. Т. 24. № 4. С. 65−73. DOI: 10.25207/1608-6228-2017-24-4-65-73

[65] Gordts S, Brosens JJ, Fusi L, et al. Uterine adenomyosis: a need for uniform terminology and consensus classification. Reprod Biomed Online. 2008;17(2):244−248. DOI: 10.1016/s1472-6483(10)60201-5

[66] Gordts S., Brosens J.J., Fusi L. et al. Uterine adenomyosis: a need for uniform terminology and consensus classifi cation // Reprod. BioMed. Online. 2008. Vol. 17. № 2. Р. 244–248. DOI: 10.1016/s1472-6483(10)60201-5

[67] Gordts S, Grimbizis G, Campo R. Symptoms and classification of uterine adenomyosis, including the place of hysteroscopy in diagnosis. Fertil Steril. 2018;109(3):380−388.e1. DOI: 10.1016/j.fertnstert.2018.01.006

[68] Gordts S., Grimbizis G., Campo R. Symptoms and classifi cation of uterine adenomyosis, including the place of hysteroscopy in diagnosis // Fertil. Steril. 2018. Vol. 109. No. 3. P. 380–388. DOI: 10.1016/j.fertnstert.2018.01.006

[69] Harada T, Khine YM, Kaponis A, et al. The impact of adenomyosis on women’s fertility. Obstet Gynecol Surv. 2016;71(9):557−568. DOI: 10.1097/OGX.0000000000000346

[70] Harada T., Khine Y.M., Kaponis A. et al. The impact of adenomyosis on women’s fertility // Obstet. Gynecol. Surv. 2016. Vol. 71. No. 9. P. 557–568. DOI: 10.1097/OGX.0000000000000346

[71] Eisenberg VH, Arbib N, Schiff E, et al. Sonographic signs of adenomyosis are prevalent in women undergoing surgery for endometriosis and may suggest a higher risk of infertility. Biomed Res Int. 2017;2017:8967803. DOI: 10.1155/2017/8967803

[72] Eisenberg V.H., Arbib N., Schiff E. et al. Sonographic signs of adenomyosis are prevalent in women undergoing surgery for endometriosis and may suggest a higher risk of infertility // Biomed. Res. Int. 2017. Vol. 2017. P. 8967803. DOI: 10.1155/2017/8967803

[73] Orekhova EK, Zhandarova OA, Kogan IYu. Reproductive outcomes in patients with thickening of the uterine J-zone (JZ). Journal of Obstetrics and Women’s Diseases. 2020;69(5):69−75. DOI: 10.17816/JOWD69569-75

[74] Орехова Е.К., Жандарова О.А., Коган И.Ю. Репродуктивные исходы у пациенток с утолщением J-зоны (JZ) матки // Журнал акушерства и женских болезней. 2020. Т. 69. № 5. C. 69−75. DOI: 10.17816/JOWD69569-75

[75] Maignien C, Santulli P, Gayet V, et al. Prognostic factors for assisted reproductive technology in women with endometriosis-related infertility. Am J Obstet Gynecol. 2017;216(3):280.e1−280.e9. DOI: 10.1016/j.ajog.2016.11.1042

[76] Maignien C., Santulli P., Gayet V. et al. Prognostic factors for assisted reproductive technology in women with endometriosis-related infertility // Am. J. Obstet. Gynecol. 2017. Vol. 216. No. 3. P. 280.e1−280.e9. DOI: 10.1016/j.ajog.2016.11.1042

[77] Exacoustos C, Brienza L, Di Giovanni A, et al. Adenomyosis: three-dimensional sonographic findings of the junctional zone and correlation with histology. Ultrasound Obstet Gynecol. 2011;37(4):471−479. DOI: 10.1002/uog.8900

[78] Exacoustos C., Brienza L., Di Giovanni A. et al. Adenomyosis: three-dimensional sonographic findings of the junctional zone and correlation with histology // Ultrasound. Obstet. Gynecol. 2011. Vol. 37. No. 4. P. 471−479. DOI: 10.1002/uog.8900

[79] Luciano DE, Exacoustos C, Albrecht L, et al. Three-dimensional ultrasound in diagnosis of adenomyosis: histologic correlation with ultrasound targeted biopsies of the uterus. J Minim Invasive Gynecol. 2013;20(6):803−810. DOI: 10.1016/j.jmig.2013.05.002

[80] Luciano D.E., Exacoustos C., Albrecht L. et al. Three-dimensional ultrasound in diagnosis of adenomyosis: histologic correlation with ultrasound targeted biopsies of the uterus // J. Minim Invasive Gynecol. 2013. Vol. 20. No. 6. P. 803−810. DOI: 10.1016/j.jmig.2013.05.002

[81] Saremi A, Bahrami H, Salehian P, et al. Treatment of adenomyomectomy in women with severe uterine adenomyosis using a novel technique. Reprod Biomed Online. 2014;28(6):753−760. DOI: 10.1016/j.rbmo.2014.02.008

[82] Saremi A., Bahrami H., Salehian P. et al. Treatment of adenomyomectomy in women with severe uterine adenomyosis using a novel technique // Reprod. Biomed. Online. 2014. Vol. 28. No. 6. P. 753−760. DOI: 10.1016/j.rbmo.2014.02.008

[83] Posiseeva LV, Gerasimov AM, Petrova UL. Glycodelin in obstetric and gynecological practice: past, present, future. Problemy Reproduktsii. 2020;26(3):11−22. DOI: 10.17116/repro20202603111

[84] Посисеева Л.В., Герасимов А.М., Петрова У.Л. Гликоделин в акушерско-гинекологической практике: прошлое, настоящее, будущее // Проблемы репродукции. 2020. Т. 26. № 3. С. 11−22. DOI: 10.17116/repro20202603111

[85] Balkhanov YuS, Kulinich SI. Implications of glycodelig for the prognosis of pregnancy. Siberian Medical Journal. 2008;83(8):49−52.

[86] Балханов Ю.С., Кулинич С.И. Значение гликоделина для прогноза вынашивания беременности // Сибирский медицинский журнал. 2008. Т. 83. № 8. С. 49−52.

[87] Arthur LD, Anthony FW, Chard T, et al. Variations in concentrations of the major endometrial secretory proteins (placental protein 14 and insulin-like growth factor binding protein-1) in assisted conception regimes. Hum Reprod. 1995;10(3):664−666. DOI: 10.1093/oxfordjournals.humrep.a136007

[88] Arthur L.D., Anthony F.W., Chard T. et al. Variations in concentrations of the major endometrial secretory proteins (placental protein 14 and insulin-like growth factor binding protein-1) in assisted conception regimes // Hum. Reprod. 1995. Vol. 10. No. 3. Р. 664−666. DOI: 10.1093/oxfordjournals.humrep.a136007

[89] Olajide F, Chard T. Biologocal and clinical significance of the endometrial protein PP14 in reproductive endocrinology. Obstet Gynecol Surv. 1992;47(4):252−257.

[90] Olajide F., Chard T. Biologocal and clinical significance of the endometrial protein PP14 in reproductive endocrinology // Obstet. Gynecol. Surv. 1992. Vol. 47. No. 4. Р. 252−257.

[91] En’kova EV, Gribanova VA, Voronina EV, Chernov AB. Immunologicheskie markery ugrozy preryvanija beremennosti. In: Modelirovanie i upravlenie processami v zdravoohranenii: mezhvuzovskij sbornik nauchnyh trudov. Voronezh; 2012. P. 101−104.

[92] Енькова Е.В., Грибанова В.А., Воронина Е.В., Чернов A.B. Иммунологические маркеры угрозы прерывания беременности // Моделирование и управление процессами в здравоохранении: межвузовский сборник научных трудов. Воронеж, 2012. С. 101−104.

[93] Mikhaleva LM, Boltovskaya MN, Mikhalev SA, et al. Endometrial dysfunction caused by chronic endometritis: сlinical and morphological aspects. Archive of Pathology. 2017;79(6):22−29. DOI: 10.17116/patol201779622-29

[94] Михалева Л.М., Болтовская М.Н., Михалев С.А. и др. Клинико-морфологические аспекты эндометриальной дисфункции, обусловленной хроническим эндометритом // Архив патологии. 2017. Т. 79. № 6. С. 22−29. DOI: 10.17116/patol201779622-29

[95] Huseynova ZS. Adenomyosis and reproductive disorders. In: International scientific review of the problems and prospects of modern science and education. International scientific review. 2019;(LV)84−87. [cited 5 Dec 2021]. Available from: https://www.elibrary.ru/download/elibrary_37234266_75471322.pdf

[96] Гусейнова З.С. Аденомиоз и нарушения репродуктивной функции // International scientific review. 2019. № LVI. С. 84−87. [дата обращения 05.12.2021]. Доступ по ссылке: https://www.elibrary.ru/download/elibrary_37234266_75471322.pdf

[97] Gladchuk IZ, Rozhkovskaya NN, Garbuzenko ND, Stamova NA. Age-related features of uterine peristalsis in infertile women with adenomyosis, uterine fibroids and their combination. Health of Woman. 2016;(3):149−152.

[98] Гладчук И.З., Рожковская Н.Н., Гарбузенко Н.Д., Стамова Н.А. Возрастные особенности маточной перистальтики у бесплодных женщин с аденомиозом, миомой матки и их сочетанием // Здоровье женщины. 2016. № 3. С. 149−152.

[99] Bergeron C, Amant F, Ferenczy A. Pathology and physiopathology of adenomyosis. Best Pract Res Clin Obstet Gynaecol. 2006;20(4):511−521. DOI: 10.1016/j.bpobgyn.2006.01.016

[100] Bergeron C., Amant F., Ferenczy A. Pathology and physiopathology of adenomyosis // Best. Pract. Res. Clin. Obstet. Gynaecol. 2006. Vol. 20. No. 4. Р. 511–521. DOI: 10.1016/j.bpobgyn.2006.01.016

[101] Kunz G, Herbertz M, Beil D, et al. Adenomyosis as a disorder of the early and late human reproductive period. Reprod Biomed Online. 2007;15(6):681−685. DOI: 10.1016/s1472-6483(10)60535-4

[102] Kunz G., Herbertz M., Beil D. et al. Adenomyosis as a disorder of the early and late human reproductive period // Reprod. Biomed. Online. 2007. Vol. 15. No. 6. P. 681−685. DOI: 10.1016/s1472-6483(10)60535-4

[103] Kutsenko II, Avakimyan VA, Kravtsova EI, Tomina OV. Application of immunocorrection in complex pregnovative preparation for ivf in patients with adenomiosis 1-2 degrees. Meditsinsky Vestnik Yuga Rossii. 2017;8(4):61−67. DOI: 10.21886/2219-8075-2017-8-4-61-67

[104] Куценко И.И., Авакимян В.А., Кравцова Е.И., Томина О.В. Применение иммунокоррекции в комплексной предгравидарной подготовке к ЭКО у пациенток с аденомиозом 1–2 степени // Медицинский вестник Юга России. 2017. Т. 8. № 4. С. 61−67. DOI: 10.21886/2219-8075-2017-8-4-61-67

[105] Graziano A, Lo Monte G, Piva I, et al. Diagnostic findings in adenomyosis: a pictorial review on the major concerns. Eur Rev Med Pharmacol Sci. 2015;19(7):1146−1154.

[106] Graziano A., Lo Monte G., Piva I. et al. Diagnostic findings in adenomyosis: a pictorial review on the major concerns // Eur. Rev. Med. Pharmacol. Sci. 2015. Vol. 19. No. 7. P. 1146−1154.

[107] Kodaman P. Current strategies for endometriosis management. Obstet Gynecol Clin North Am. 2015;42(1):87–101. DOI: 10.1016/j.ogc.2014.10.005

[108] Kodaman P. Current strategies for endometriosis management // Obstet. Gynecol. Clin. North Am. 2015. Vol. 42. No. 1. Р. 87–101. DOI: 10.1016/j.ogc.2014.10.005

[109] Kozachenko IF, Adamyan LV. Reproductive function in patients with adenomyosis after organ-preserving operations. Obstetrics and gynecology: News. Opinions. Training. 2020;2(28):59−66. DOI: 10.24411/2303-9698-2020-12005

[110] Козаченко И.Ф., Адамян Л.В. Восстановление репродуктивной функции у больных аденомиозом после проведения органосохраняющих операций // Акушерство и гинекология: Новости. Мнения. Обучения. 2020. № 2 (28). С. 59−66. DOI: 10.24411/2303-9698-2020-12005

[111] Donnez J, Donnez O, Dolmans MM. Introduction: Uterine adenomyosis, another enigmatic disease of our time. Fertil Steril. 2018;109(3):369−370. DOI: 10.1016/j.fertnstert.2018.01.035

[112] Donnez J., Donnez O., Dolmans M.M. Introduction: uterine adenomyosis, another enigmatic disease of our time // Fertil. Steril. 2018. Vol. 109. No. 3. P. 369–370. DOI: 10.1016/j.fertnstert.2018.01.035

[113] Horton J, Sterrenburg M, Lane S, et al. Reproductive, obstetric, and perinatal outcomes of women with adenomyosis and endometriosis: a systematic review and meta-analysis. Hum Reprod Update. 2019;25(5):592−632. DOI: 10.1093/humupd/dmz012

[114] Horton J., Sterrenburg M., Lane S. et al. Reproductive, obstetric, and perinatal outcomes of women with adenomyosis and endometriosis: a systematic review and meta-analysis // Hum. Reprod. Update. 2019. Vol. 25. No. 5. Р. 593–633. DOI: 10.1093/humupd/dmz012

[115] Yoldemir T. Adenomyosis and fertility outcomes. Gynecol Endocrinol. 2020;36(6):473−474. DOI: 10.1080/09513590.2020.1773426

[116] Yoldemir T. Adenomyosis and fertility outcomes // Gynecol. Endocrinol. 2020. Vol. 36. No. 6. Р. 473−474. DOI: 10.1080/09513590.2020.1773426

[117] Vercellini P, Consonni D, Dridi D, et al. Uterine adenomyosis and in vitro fertilization outcome: a systematic review and meta-analysis. Hum Reprod. 2014;29(5):964−977. DOI: 10.1093/humrep/deu041

[118] Vercellini P., Consonni D., Dridi D. et al. Uterine adenomyosis and in vitro fertilization outcome: a systematic review and meta-analysis // Hum. Reprod. 2014. Vol. 29. No. 5. Р. 964–977. DOI: 10.1093/humrep/deu041

[119] Gabidullina RI, Kuptsova AI, Koshelnikova EA, et al. Adenomyosis: clinical aspects, impact on fertility and pregnancy outcomes. Gynecology. 2020;(4):55−61. DOI: 10.26442/20795696.2020.4.200264

[120] Габидуллина Р.И., Купцова А.И., Кошельникова Е.А. и др. Аденомиоз: клинические аспекты, влияние на фертильность и исходы беременности // Гинекология. 2020. № 4. С. 55−61. DOI: 10.26442/20795696.2020.4.200264

[121] Vannuccini S, Petraglia F. Recent advances in understanding and managing adenomyosis. F1000Res. 2019;8:F1000 Faculty Rev-283. DOI: 10.12688/f1000research.17242.1

[122] Vannuccini S., Petraglia F. Recent advances in understanding and managing adenomyosis // F1000Res. 2019. Vol. 8. P. F1000 Faculty Rev-283. DOI: 10.12688/f1000research.17242.1

[123] Tapilskaya NI, Gaidukov SN, Shanina TB. Adenomyosis as a separate phenotype of endometrial dysfunction. Jeffektivnaja farmakoterapija. 2015;(5):62−68.

[124] Тапильская Н.И., Гайдуков С.Н., Шанина Т.Б. Аденомиоз как самостоятельный фенотип дисфункции эндомиометрия // Эффективная фармакотерапия. 2015. № 5. C. 62−68.

[125] Healy DL, Breheny S, Halliday J, et al. Prevalence and risk factors for obstetric haemorrhage in 6730 singleton births after assisted reproductive technology in Victoria Australia. Hum Reprod. 2010;25(1):265−274. DOI: 10.1093/humrep/dep376

[126] Healy D.L., Breheny S., Halliday J. et al. Prevalence and risk factors for obstetric haemorrhage in 6730 singleton births after assisted reproductive technology in Victoria Australia // Hum. Reprod. 2010. Vol. 25. No. 1. P. 265−274. DOI: 10.1093/humrep/dep376

[127] Tamura H, Kishi H, Kitade M, et al. Complications and outcomes of pregnant women with adenomyosis in Japan. Reprod Med Biol. 2017;16(4):330−336. DOI: 10.1002/rmb2.12050

[128] Tamura H., Kishi H., Kitade M. et al. Complications and outcomes of pregnant women with adenomyosis in Japan // Reprod. Med. Biol. 2017. Vol. 16. No. 4. P. 330−336. DOI: 10.1002/rmb2.12050

RIGHTS & PERMISSIONS

Eсо-Vector